Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance
Work
Year: 2006
Type: article
Abstract: This guidance describes how the FDA evaluates patient-reported outcome (PRO) instruments used as effectiveness endpoints in clinical trials. It also describes our current thinking on how sponsors can ... more
Cites:
Cited by: 2,499
Related to: 10
FWCI: 51.16
Citation percentile (by year/subfield): 100
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: gold
APC paid (est): $2,318